News
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Aurora Cannabis posted mixed Q1 FY2026 results, facing sales pressure, covenant issues, and looming German regulatory risks.
Stocktwits on MSN2d
Retail Bulls Pile Into Cannabis Stocks On Reports Trump May Reclassify Marijuana; Traders Eye Aurora Rally
Canopy Growth (CGC), Cronos Group (CRON) and Trulieve Cannabis (TCNNF) after reports that U.S. President Donald Trump may ...
If you invested in Canadian cannabis stocks just after legalization in 2018, at the height of investor fervor, you are likely ...
Shares of major cannabis companies are trading higher Monday morning. The stocks are soaring following a WSJ report that ...
U.S. President Donald Trump’s administration is looking to reclassify marijuana as a less dangerous drug, a shift that could ...
Greetings and welcome to Aurora Cannabis Incorporated Fiscal First Quarter 2026 Results Conference Call all participants will ...
To say Aurora Cannabis (NASDAQ: ACB) has faced some challenges over the years would be a huge understatement. The once-leading cannabis producer in the Canadian marijuana industry is now a shell ...
With a share price down 99.5% from its early 2019 highs, $225 million in sales, and $818 million in annual losses, on the surface at least, Canadian marijuana stock Aurora Cannabis (ACB) stock ...
The Aurora City Council on Monday night gave preliminary approval, by an 8-2 vote, to cannabis delivery in Colorado’s third-largest city.
Should you buy Aurora Cannabis' stock today? Although Aurora is getting closer to adjusted EBITDA profitability, its net loss was still CA$51.9 million in Q1.
Potency Cultivars, Expanding Patient Choice in Australia EDMONTON, ALBERTA, Aug. 12, 2025 /CNW/ – Aurora Cannabis Inc. (NASDAQ: ACB) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback